Overview
- The Brown University analysis of Medicare and electronic health‑record data, published Friday, June 19, 2026, found vaccinated nursing‑facility residents had about a 24% lower relative risk of receiving a dementia diagnosis over four years compared with unvaccinated residents.
- The study examined more than 500,000 people admitted to skilled nursing facilities between 2017 and 2022 but only 8,843 received at least one dose of the recombinant zoster vaccine (RZV, Shingrix), which limits subgroup power and generalizability.
- Authors used a target‑trial emulation design and adjusted for many health and demographic factors, yet they and outside experts caution that residual confounding can’t be ruled out and the results do not prove causation.
- Plausible explanations include prevention of shingles‑related neuroinflammation or stroke and non‑specific immune stimulation from the vaccine’s adjuvant, but the biological mechanism remains unproven and under study.
- The findings add to earlier observational reports from other countries and have prompted calls for randomized or large comparative trials, with researchers noting low vaccine uptake in some populations and disclosing that the study received GSK funding without company control of the analysis.